IRON
Disc Medicine, Inc.Company Information
- Company Name
- Disc Medicine, Inc.
- CIK
- CIK0001816736
- Category
- Large accelerated filer
- Ticker: Exchange
- IRON: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- IRON
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-06-17
- Last sale
- 2026-09-11
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 1,287,702
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 40,827,100
- Shares outstanding
- 38,685,565
- Ownership
- 105.54%
Earnings Market Reaction
- Filing date
- 2026-07-30
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 99 | 89 | 91 | 141 | 127 | 123 | 192 | 193 | 281 | 343 | 360 | 371 | ||||||
| Marketable Securities Current | 619 | 641 | 700 | 475 | 523 | 572 | 297 | 295 | 220 | - | 0 | - | ||||||
| Prepaid Expense And Other Assets Current | 15 | 17 | 13 | 11 | 12 | 11 | 4 | 6 | 7 | 9 | 5 | 4 | ||||||
| Assets Current | 733 | 747 | 804 | 627 | 662 | 706 | 494 | 493 | 508 | 352 | 366 | 374 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Other Assets Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 735 | 750 | 807 | 630 | 665 | 709 | 497 | 495 | 510 | 354 | 368 | 376 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 7 | 12 | 9 | 7 | 6 | 7 | 8 | 4 | 5 | 5 | 13 | 8 | ||||||
| Accrued Liabilities Current | 9 | 7 | 16 | 11 | 6 | 4 | 8 | 6 | 4 | 9 | 6 | 6 | ||||||
| Operating Lease Liability Current | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | ||||||
| Liabilities Current | 30 | 31 | 37 | 27 | 21 | 19 | 23 | 25 | 20 | 15 | 21 | 14 | ||||||
| Long Term Debt | 59 | 29 | 29 | 29 | 29 | 29 | 28 | - | - | - | 0 | - | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | ||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 2 | ||||||
| Liabilities | 91 | 62 | 67 | 57 | 51 | 49 | 53 | 27 | 21 | 16 | 23 | 18 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 1,279 | 1,263 | 1,249 | 1,022 | 1,001 | 992 | 741 | 736 | 731 | 554 | 534 | 524 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -2 | -1 | 1 | 1 | 0 | 1 | 0 | 1 | -0 | - | 0 | - | ||||||
| Retained Earnings Accumulated Deficit | -633 | -574 | -510 | -450 | -387 | -332 | -298 | -269 | -242 | -216 | -189 | -165 | ||||||
| Stockholders Equity | 644 | 688 | 740 | 573 | 614 | 660 | 444 | 468 | 489 | 338 | 345 | 359 | ||||||
| Liabilities And Stockholders Equity | 735 | 750 | 807 | 630 | 665 | 709 | 497 | 495 | 510 | 354 | 368 | 376 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | - | - | 10 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 38 | 38 | 38 | 35 | 35 | 35 | 30 | 30 | 30 | 25 | 24 | 24 | ||||||
| Shares Outstanding | 38 | 38 | 38 | 35 | 35 | 35 | 30 | 30 | 30 | 25 | 24 | 24 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialDisc Medicine, Inc. (IRON) — SEC Financial Statements & Analysis
Disc Medicine, Inc. (IRON) is a pharmaceutical preparations company. Disc Medicine, Inc. trades on Nasdaq as: IRON. Disc Medicine, Inc. (IRON)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, Disc Medicine, Inc. carries a market cap of $2.83B, a P/E ratio of -11.51x, a P/B ratio of 4.39x, an enterprise value of $2.79B, and an EV/EBITDA multiple of -10.37x. On profitability, it posts a Return on Equity (ROE) of -39.08%, a Return on Assets (ROA) of -35.12%, and a Return on Invested Capital (ROIC) of -48.03%. Per share, it reports EPS of $-6.36, diluted EPS of $-6.36, free cash flow per share of $-5.11, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 69.13% year-over-year and EPS growth of 53.12% year-over-year. On the balance sheet, it maintains a current ratio of 24.14x, a quick ratio of 23.64x, working capital of $702.40M, a debt-to-equity ratio of 0.14x, a debt ratio of 0.12, an interest coverage ratio of -75.81x, free cash flow of $-197.58M (TTM), and net debt of $-39.58M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.83B
- P/E TTM
- -11.51x
- EPS TTM
- $-6.36
- P/B TTM
- 4.39x
- ROE TTM
- -39.08%
- ROA TTM
- -35.12%
- Debt To Equity
- 0.14x
- Free Cash Flow TTM
- $-197.58M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Disc Medicine, Inc. in?
Disc Medicine, Inc. (IRON) operates in the Pharmaceutical Preparations industry.
What exchange does IRON trade on?
Disc Medicine, Inc. (IRON) trades on the Nasdaq.
When was Disc Medicine, Inc. (IRON)'s most recent SEC filing?
Disc Medicine, Inc. (IRON)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30.
What is IRON's market cap?
Disc Medicine, Inc. (IRON) has a market capitalization of $2.83B as of 2026-06-30.
What is IRON's EPS (earnings per share)?
Disc Medicine, Inc. (IRON)'s trailing twelve month EPS is $-6.36 as of 2026-06-30.
What is IRON's ROE (return on equity)?
Disc Medicine, Inc. (IRON)'s trailing twelve month Return on Equity (ROE) is -39.08% as of 2026-06-30.
What is IRON's ROA (return on assets)?
Disc Medicine, Inc. (IRON)'s trailing twelve month Return on Assets (ROA) is -35.12% as of 2026-06-30.
What is IRON's ROIC (return on invested capital)?
Disc Medicine, Inc. (IRON)'s trailing twelve month Return on Invested Capital (ROIC) is -48.03% as of 2026-06-30.
What is IRON's EV/EBITDA?
Disc Medicine, Inc. (IRON)'s trailing twelve month EV/EBITDA is -10.37x as of 2026-06-30.